Oxford Industries (OXM) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
8 Jul, 2026Executive summary
Q2 FY2025 net sales were $403 million, down 4% year-over-year, with adjusted EPS of $1.26, exceeding guidance despite tariff and promotional pressures.
Operating income fell 52% to $25 million, and net earnings dropped 59% to $16.7 million, reflecting lower sales, higher SG&A, and increased tariffs.
Lilly Pulitzer posted positive direct-to-consumer comp sales, while Tommy Bahama and Johnny Was faced declines but are implementing corrective actions.
Emerging Brands Group delivered solid revenue growth from new stores and positive comp sales.
Tariff mitigation and disciplined inventory management helped offset some margin pressures.
Financial highlights
Q2 FY2025 consolidated net sales were $403 million, down from $420 million in Q2 FY2024, near the midpoint of guidance.
Adjusted gross margin contracted to 61.7% (GAAP 61.4%), mainly due to $9 million in increased tariff-related costs.
Adjusted SG&A rose to $224 million, driven by higher employment, occupancy, and depreciation costs from new stores.
Adjusted operating profit was $28 million (7% margin), down from $57 million (13.5% margin) last year.
Adjusted EPS was $1.26 for the quarter.
Outlook and guidance
FY2025 net sales expected between $1.475 billion and $1.515 billion, near flat versus FY2024.
Adjusted EPS guidance for FY2025 is $2.80–$3.20, down from $6.68 last year.
Gross margin expected to contract by ~200 bps for the year, mainly due to tariffs.
Q3 sales expected at $295 million–$310 million, with an adjusted loss per share of $1.05 to $0.85.
Management remains cautious due to macroeconomic uncertainty, ongoing tariff risks, and heightened promotional activity.
Latest events from Oxford Industries
- Q3 sales and earnings declined due to hurricanes and macro headwinds, but holiday trends improved.OXM
Q3 20258 Jul 2026 - Flat sales and margin pressure from tariffs, with higher adjusted EPS and narrowed FY26 guidance.OXM
Q1 202711 Jun 2026 - Shareholders will vote on directors, equity plan amendments, auditor ratification, and executive pay.OXM
Proxy filing13 May 2026 - Virtual annual meeting to vote on directors, stock plan, auditor, and executive pay; online access promoted.OXM
Proxy filing13 May 2026 - 2026 guidance targets flat to 4% sales growth, margin expansion, and debt reduction amid tariff and cost headwinds.OXM
Q4 202626 Mar 2026 - Q1 sales and earnings fell, but FY24 growth and investment are expected despite headwinds.OXM
Q1 20253 Feb 2026 - Earnings and margins fell on flat sales as guidance was cut and capex increased for growth.OXM
Q2 202520 Jan 2026 - Cost controls, sourcing shifts, and brand focus aim to drive a 2026 recovery after a tough 2025.OXM
28th Annual ICR Conference 202612 Jan 2026 - Strong brands, resilient margins, and strategic investments set the stage for 2025 growth.OXM
27th Annual ICR Conference 202510 Jan 2026